Clinical trials
Phase 4 Alzheimer Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 3 |
| 2003 | 4 |
| 2004 | 1 |
| 2005 | 5 |
| 2006 | 4 |
| 2007 | 5 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 5 |
| 2013 | 3 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2022 | 3 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
| Recruiting | 5 |
| Terminated | 4 |
| Withdrawn | 3 |
| Enrolling by invitation | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| NYU Langone Health | 4 |
| New York State Psychiatric Institute | 4 |
| Avid Radiopharmaceuticals | 3 |
| Eisai Inc. | 3 |
| Novartis | 3 |
| VA Office of Research and Development | 3 |
| Duke University | 2 |
| Emory University | 2 |
| Johns Hopkins University | 2 |
| Mayo Clinic | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 57 |
| Dementia | 16 |
| Cognitive Dysfunction | 9 |
| Psychomotor Agitation | 5 |
| Cognition Disorders | 3 |
| Lethargy | 3 |
| Plaque, Amyloid | 3 |
| Psychotic Disorders | 3 |
| Anosmia | 2 |
| Dementia, Vascular | 2 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.